Clinical Trial

We-INtervention Among Chinese HIV-serodiscordant Male Couples

Recruiting
View on ClinicalTrials.gov →
Summary
HIV-serodiscordant male couples, in which one male partner is HIV-seropositive and the other is HIV-seronegative, experience multiple risks in HIV care and prevention. As stigma often hinders such couples' access to support and services, leveraging their relational resources is crucial for optimizing their outcomes. The proposed study will assess the efficacy of the three-session We-INtervention focusing on their relationship dynamics to enhance Chinese HIV-serodiscordant male couples' health and well-being. A total of 160 Chinese HIV-serodiscordant male couples (320 individuals: 160 HIV-seropositive and 160 HIV-seronegative) will be randomized at a 1:1 ratio to either the intervention or control arm. In the intervention arm, the We-INtervention will be delivered to both partners of each couple separately. In the control arm, each couple will receive health information pamphlets.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-10.
Status change: Not Yet Recruiting → Recruiting 2026-01-18
Trial Details
NCT Number NCT06639932
Lead Sponsor City University of Hong Kong
Conditions HIV
Enrollment 320 participants
Start Date 2025-09-01
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-21